Nordea Investment Management AB Has $13.17 Million Stock Holdings in STERIS plc $STE

Key Points

• Nordea Investment Management AB boosted its stake in STERIS by 259.0% in Q4 to 51,602 shares, worth about $13.17 million (≈0.05% of the company).
• STERIS reported quarterly EPS of $2.53 (in line with estimates), revenue up 9.2% year‑over‑year, and set FY 2026 guidance of $10.15–$10.30 EPS.
• Sell‑side analysts hold a consensus rating of Moderate Buy with a consensus target price of $275.20 (six Buys, two Holds).

Nordea Investment Management AB grew its stake in shares of STERIS plc (NYSE:STE - Free Report) by 259.0% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 51,602 shares of the medical equipment provider's stock after acquiring an additional 37,228 shares during the quarter. Nordea Investment Management AB owned about 0.05% of STERIS worth $13,165,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Jones Financial Companies Lllp increased its position in shares of STERIS by 46.1% in the first quarter. Jones Financial Companies Lllp now owns 1,106 shares of the medical equipment provider's stock worth $251,000 after purchasing an additional 349 shares during the period. Goldman Sachs Group Inc. lifted its position in STERIS by 32.3% during the first quarter. Goldman Sachs Group Inc. now owns 242,732 shares of the medical equipment provider's stock worth $55,015,000 after purchasing an additional 59,264 shares during the period. Empowered Funds LLC lifted its position in STERIS by 16.1% during the first quarter. Empowered Funds LLC now owns 2,303 shares of the medical equipment provider's stock worth $522,000 after purchasing an additional 319 shares during the period. Woodline Partners LP grew its stake in STERIS by 40.0% during the first quarter. Woodline Partners LP now owns 8,300 shares of the medical equipment provider's stock worth $1,881,000 after buying an additional 2,372 shares in the last quarter. Finally, Jane Street Group LLC increased its holdings in STERIS by 38.9% in the 1st quarter. Jane Street Group LLC now owns 20,716 shares of the medical equipment provider's stock valued at $4,695,000 after buying an additional 5,803 shares during the period. 94.69% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on STE. Weiss Ratings restated a "buy (b)" rating on shares of STERIS in a research report on Friday, January 9th. Wall Street Zen upgraded shares of STERIS from a "buy" rating to a "strong-buy" rating in a research report on Saturday, March 7th. Six analysts have rated the stock with a Buy rating and two have given a Hold rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $275.20.

Insider Activity

In related news, Director Cynthia L. Feldmann sold 3,098 shares of the company's stock in a transaction that occurred on Thursday, March 5th. The shares were sold at an average price of $237.21, for a total transaction of $734,876.58. Following the completion of the transaction, the director directly owned 705 shares in the company, valued at $167,233.05. This represents a 81.46% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 1.07% of the company's stock.

STERIS Price Performance

Shares of STE stock opened at $222.04 on Wednesday. The company has a quick ratio of 1.75, a current ratio of 2.48 and a debt-to-equity ratio of 0.26. STERIS plc has a twelve month low of $204.90 and a twelve month high of $269.44. The company has a market cap of $21.78 billion, a P/E ratio of 30.97 and a beta of 1.05. The business has a fifty day simple moving average of $245.43 and a 200 day simple moving average of $249.32.

STERIS (NYSE:STE - Get Free Report) last released its quarterly earnings data on Wednesday, February 4th. The medical equipment provider reported $2.53 earnings per share for the quarter, meeting the consensus estimate of $2.53. STERIS had a return on equity of 14.34% and a net margin of 12.15%.The firm's revenue was up 9.2% on a year-over-year basis. During the same period last year, the firm earned $2.32 EPS. STERIS has set its FY 2026 guidance at 10.150-10.300 EPS. On average, sell-side analysts forecast that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, March 19th. Investors of record on Tuesday, February 17th were issued a dividend of $0.63 per share. The ex-dividend date of this dividend was Tuesday, February 17th. This represents a $2.52 annualized dividend and a dividend yield of 1.1%. STERIS's payout ratio is 35.15%.

About STERIS

STERIS Corporation NYSE: STE is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.

Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STERIS plc (NYSE:STE - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.